Subtopic Deep Dive
Molecular Hydrogen in Neuroprotection
Research Guide
What is Molecular Hydrogen in Neuroprotection?
Molecular hydrogen in neuroprotection refers to the therapeutic use of H2 gas or hydrogen-rich water to reduce oxidative stress and protect neurons in neurodegenerative diseases like Parkinson's and Alzheimer's.
Studies demonstrate H2's ability to penetrate the blood-brain barrier and selectively neutralize hydroxyl radicals (Ohta, 2011; 294 citations). Hydrogen water reduced dopaminergic neuronal loss in MPTP Parkinson's mouse models (Fujita et al., 2009; 198 citations). Over 300 original articles review H2's beneficial effects across 321 studies (Ichihara et al., 2015; 262 citations).
Why It Matters
H2 neuroprotection targets oxidative damage in stroke, Parkinson's, and Alzheimer's models via Nrf2 activation, offering safe inhalation or water-based therapies (Ohta, 2011). In MPTP mouse models, hydrogen drinking water preserved dopamine neurons against chronic oxidative stress (Fujita et al., 2009). Comprehensive reviews confirm H2's preventive potential for lifestyle-related brain disorders (Ichihara et al., 2015; Li et al., 2017). This addresses unmet needs in neurodegenerative treatments where antioxidants fail due to poor brain penetration.
Key Research Challenges
Blood-Brain Barrier Penetration
H2 must cross the BBB to reach neurons amid oxidative stress from ROS imbalance (Rahman et al., 2012; 481 citations). Delivery methods like inhalation versus water vary in efficacy for brain protection. Studies confirm H2's diffusion but require optimized dosing for clinical translation (Ohta, 2011).
Selective Antioxidant Mechanisms
H2 selectively scavenges hydroxyl radicals without disrupting beneficial ROS signaling (Ohta, 2011; 294 citations). Mechanisms involve Nrf2 pathway activation, but downstream effects in neurodegeneration need clarification. MPTP models show neuronal preservation, yet human applicability remains unproven (Fujita et al., 2009).
Clinical Translation from Models
Preclinical success in Parkinson's mouse models lacks large-scale human trials (Fujita et al., 2009; 198 citations). Variability in oxidative stress responses across species complicates dosing (Rahman et al., 2012). Reviews highlight need for standardized protocols in stroke and Alzheimer's (Ichihara et al., 2015).
Essential Papers
Oxidative stress and human health
Taibur Rahman, Md. Ismail Hosen, Md. Monirul Islam et al. · 2012 · Advances in Bioscience and Biotechnology · 481 citations
Redox degenerative reactions of the biological system inevitably produce reactive oxygen species (ROS) and their derivatives. Oxidative stress is the result of an imbalance in pro-oxidant/antioxida...
Emergence of Hydrogen Sulfide as an Endogenous Gaseous Signaling Molecule in Cardiovascular Disease
David J. Polhemus, David J. Lefer · 2014 · Circulation Research · 431 citations
Long recognized as a malodorous and highly toxic gas, recent experimental studies have revealed that hydrogen sulfide (H 2 S) is produced enzymatically in all mammalian species including man and ex...
Mechanisms of Action Involved in Ozone Therapy: Is healing induced via a mild oxidative stress?
Masaru Sagai, Velio Bocci · 2011 · Medical Gas Research · 380 citations
The potential mechanisms of action of ozone therapy are reviewed in this paper. The therapeutic efficacy of ozone therapy may be partly due the controlled and moderate oxidative stress produced by ...
<i>Portulaca oleracea</i>L.: A Review of Phytochemistry and Pharmacological Effects
Yanxi Zhou, Hailiang Xin, Khalid Rahman et al. · 2015 · BioMed Research International · 367 citations
Portulaca oleracea L., belonging to the Portulacaceae family, is commonly known as purslane in English and Ma-Chi-Xian in Chinese. It is a warm-climate, herbaceous succulent annual plant with a cos...
Local generation of hydrogen for enhanced photothermal therapy
Penghe Zhao, Zhaokui Jin, Qian Chen et al. · 2018 · Nature Communications · 362 citations
Recent Progress Toward Hydrogen Medicine: Potential of Molecular Hydrogen for Preventive and Therapeutic Applications
Shigeo Ohta · 2011 · Current Pharmaceutical Design · 294 citations
Persistent oxidative stress is one of the major causes of most lifestyle-related diseases, cancer and the aging process. Acute oxidative stress directly causes serious damage to tissues. Despite th...
Beneficial biological effects and the underlying mechanisms of molecular hydrogen - comprehensive review of 321 original articles -
Masatoshi Ichihara, Sayaka Sobue, Mikako Ito et al. · 2015 · Medical Gas Research · 262 citations
Reading Guide
Foundational Papers
Start with Ohta (2011; 294 citations) for H2's antioxidant mechanisms and Fujita et al. (2009; 198 citations) for Parkinson's MPTP evidence, as they establish core neuroprotective effects.
Recent Advances
Study Ichihara et al. (2015; 262 citations) for 321-article H2 review and Li et al. (2017; 208 citations) for disease applications including neurodegeneration.
Core Methods
Core techniques: hydrogen water administration (Fujita et al., 2009), ROS measurement via biomarkers (Rahman et al., 2012), Nrf2 pathway assays, and inhalation delivery (Ohta, 2011).
How PapersFlow Helps You Research Molecular Hydrogen in Neuroprotection
Discover & Search
Research Agent uses searchPapers('molecular hydrogen neuroprotection Parkinson's') to find Fujita et al. (2009), then citationGraph reveals 198 citing papers on H2 in neurodegeneration, and findSimilarPapers expands to Ohta (2011) for mechanisms.
Analyze & Verify
Analysis Agent applies readPaperContent on Fujita et al. (2009) to extract MPTP model data, verifyResponse with CoVe checks H2's neuronal protection claims against Rahman et al. (2012), and runPythonAnalysis plots ROS reduction stats with GRADE scoring for evidence strength.
Synthesize & Write
Synthesis Agent detects gaps in clinical trials via contradiction flagging between preclinical models (Fujita et al., 2009) and human needs, while Writing Agent uses latexEditText, latexSyncCitations for Ohta (2011), and latexCompile to generate a review manuscript with exportMermaid for Nrf2 pathway diagrams.
Use Cases
"Analyze neuronal loss data from hydrogen water in MPTP Parkinson's models"
Research Agent → searchPapers → Analysis Agent → readPaperContent(Fujita 2009) → runPythonAnalysis(NumPy plot dopamine neuron counts) → matplotlib graph of protection efficacy.
"Write LaTeX review on H2 mechanisms in neuroprotection citing Ohta 2011"
Synthesis Agent → gap detection → Writing Agent → latexEditText(intro section) → latexSyncCitations(Ohta 2011, Ichihara 2015) → latexCompile → PDF with Nrf2 diagram via exportMermaid.
"Find code for simulating H2 ROS scavenging in brain models"
Research Agent → searchPapers(H2 oxidative stress) → Code Discovery → paperExtractUrls → paperFindGithubRepo → githubRepoInspect → Python script for radical quenching kinetics.
Automated Workflows
Deep Research workflow runs searchPapers on 'H2 neuroprotection' → citationGraph(50+ papers) → structured report with GRADE scores on Fujita et al. (2009). DeepScan applies 7-step CoVe analysis to verify Ohta (2011) mechanisms against Rahman et al. (2012) ROS data. Theorizer generates hypotheses on H2-Nrf2 interactions from Ichihara et al. (2015) review.
Frequently Asked Questions
What defines molecular hydrogen in neuroprotection?
Molecular hydrogen (H2) acts as a selective antioxidant that penetrates the blood-brain barrier to mitigate oxidative neuronal damage in Parkinson's and stroke models (Ohta, 2011).
What are key methods for H2 delivery in neuroprotection studies?
Methods include hydrogen-rich drinking water in MPTP mouse models reducing dopaminergic loss (Fujita et al., 2009) and gas inhalation for acute oxidative stress (Ohta, 2011).
What are the most cited papers?
Rahman et al. (2012; 481 citations) on oxidative stress, Ohta (2011; 294 citations) on H2 medicine, and Fujita et al. (2009; 198 citations) on Parkinson's neuroprotection.
What open problems exist?
Challenges include clinical trial gaps beyond mouse models (Fujita et al., 2009), optimal BBB delivery dosing, and human validation of Nrf2 mechanisms (Ichihara et al., 2015).
Research Hydrogen's biological and therapeutic effects with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Molecular Hydrogen in Neuroprotection with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers